- Home
- WTTR vs CLDX Comparison
WTTR vs CLDX Comparison
Compare WTTR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- CLDX
- Stock Information
- Founded
- WTTR 2016
- CLDX 1983
- Country
- WTTR United States
- CLDX United States
- Employees
- WTTR N/A
- CLDX N/A
- Industry
- WTTR Oilfield Services/Equipment
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WTTR Energy
- CLDX Health Care
- Exchange
- WTTR Nasdaq
- CLDX Nasdaq
- Market Cap
- WTTR 1.4B
- CLDX 1.7B
- IPO Year
- WTTR 2017
- CLDX 2008
- Fundamental
- Price
- WTTR $13.30
- CLDX $23.77
- Analyst Decision
- WTTR Strong Buy
- CLDX Buy
- Analyst Count
- WTTR 2
- CLDX 7
- Target Price
- WTTR $16.25
- CLDX $64.83
- AVG Volume (30 Days)
- WTTR 803.4K
- CLDX 1.1M
- Earning Date
- WTTR 02-18-2025
- CLDX 02-24-2025
- Dividend Yield
- WTTR 2.10%
- CLDX N/A
- EPS Growth
- WTTR 11.32
- CLDX N/A
- EPS
- WTTR 0.59
- CLDX N/A
- Revenue
- WTTR $1,477,888,000.00
- CLDX $9,976,000.00
- Revenue This Year
- WTTR N/A
- CLDX N/A
- Revenue Next Year
- WTTR $5.32
- CLDX N/A
- P/E Ratio
- WTTR $22.63
- CLDX N/A
- Revenue Growth
- WTTR N/A
- CLDX 128.55
- 52 Week Low
- WTTR $7.40
- CLDX $22.17
- 52 Week High
- WTTR $15.14
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- WTTR 33.21
- CLDX 42.32
- Support Level
- WTTR $12.73
- CLDX $23.55
- Resistance Level
- WTTR $13.26
- CLDX $26.26
- Average True Range (ATR)
- WTTR 0.47
- CLDX 1.24
- MACD
- WTTR -0.16
- CLDX 0.08
- Stochastic Oscillator
- WTTR 4.71
- CLDX 36.19
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates the majority of its revenue from Water Services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.